CGEM Operating Cash Flow (Statement)
Cullinan Therapeutics Inc · Operating Cash Flow (Statement)
CGEM Operating Cash Flow (Statement)
Latest reported-$38.22Mperiod ending
CGEM Quarterly Cash from Operations (-$5.08M → -$38.22M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
CGEM operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -38,219,000 | |
| -46,045,000 | |
| -38,109,000 | |
| -36,877,000 | |
| -57,609,000 | |
| -43,155,000 | |
| -36,626,000 | |
| -34,139,000 | |
| -36,291,000 | |
| -38,247,000 | |
| -18,131,000 | |
| -34,141,000 | |
| -31,006,000 | |
| -50,997,000 | |
| -24,983,000 | |
| -54,353,000 | |
| -25,420,000 | |
| -21,908,000 | |
| -15,171,000 | |
| -10,551,000 | |
| -16,196,000 | |
| -1,515,000 | |
| -9,436,000 | |
| -9,071,000 | |
| -6,250,000 | |
| -5,015,000 | |
| -4,869,000 | |
| -5,867,000 | |
| -5,080,500 | |
| -5,080,500 |